Sherwin-Williams (SHW) Upgraded to Outperform by Wells Fargo & Co

Sherwin-Williams (NYSE:SHW) was upgraded by equities researchers at Wells Fargo & Co from a “market perform” rating to an “outperform” rating in a report issued on Monday, Marketbeat Ratings reports. The brokerage presently has a $475.00 price target on the specialty chemicals company’s stock. Wells Fargo & Co‘s price objective indicates a potential upside of 19.36% from the stock’s current price.

A number of other analysts also recently issued reports on the stock. Citigroup upgraded shares of Sherwin-Williams from a “neutral” rating to a “buy” rating in a report on Friday, January 4th. JPMorgan Chase & Co. upgraded shares of Sherwin-Williams from a “neutral” rating to an “overweight” rating and raised their price target for the stock from $380.00 to $415.00 in a report on Monday, December 17th. Deutsche Bank upgraded shares of Sherwin-Williams from a “hold” rating to a “buy” rating and raised their price target for the stock from $400.00 to $465.00 in a report on Tuesday, December 4th. Longbow Research assumed coverage on shares of Sherwin-Williams in a report on Friday, November 30th. They set a “neutral” rating for the company. Finally, Argus set a $480.00 price target on shares of Sherwin-Williams and gave the stock a “buy” rating in a report on Monday, October 29th. Eight analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $462.26.

Shares of NYSE SHW traded up $2.02 during midday trading on Monday, reaching $397.95. 2,763 shares of the stock were exchanged, compared to its average volume of 733,200. The company has a market capitalization of $37.28 billion, a P/E ratio of 27.78, a P/E/G ratio of 1.40 and a beta of 1.31. The company has a debt-to-equity ratio of 2.19, a current ratio of 1.04 and a quick ratio of 0.66. Sherwin-Williams has a twelve month low of $355.28 and a twelve month high of $479.64.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings results on Thursday, October 25th. The specialty chemicals company reported $5.68 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $5.71 by ($0.03). The firm had revenue of $4.73 billion for the quarter, compared to analyst estimates of $4.78 billion. Sherwin-Williams had a return on equity of 45.22% and a net margin of 10.92%. As a group, research analysts expect that Sherwin-Williams will post 19.11 EPS for the current year.

In related news, Director John M. Stropki acquired 675 shares of the stock in a transaction that occurred on Monday, October 29th. The stock was purchased at an average price of $375.00 per share, with a total value of $253,125.00. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.78% of the company’s stock.

Large investors have recently bought and sold shares of the stock. Carroll Financial Associates Inc. boosted its position in Sherwin-Williams by 4.3% in the 4th quarter. Carroll Financial Associates Inc. now owns 657 shares of the specialty chemicals company’s stock valued at $260,000 after buying an additional 27 shares during the period. Peninsula Asset Management Inc. boosted its position in Sherwin-Williams by 1.1% in the 2nd quarter. Peninsula Asset Management Inc. now owns 11,147 shares of the specialty chemicals company’s stock valued at $4,543,000 after buying an additional 117 shares during the period. Cypress Capital Group boosted its position in Sherwin-Williams by 2.8% in the 2nd quarter. Cypress Capital Group now owns 4,651 shares of the specialty chemicals company’s stock valued at $1,896,000 after buying an additional 128 shares during the period. Centaurus Financial Inc. boosted its position in Sherwin-Williams by 10.6% in the 2nd quarter. Centaurus Financial Inc. now owns 1,357 shares of the specialty chemicals company’s stock valued at $553,000 after buying an additional 130 shares during the period. Finally, Valeo Financial Advisors LLC boosted its position in Sherwin-Williams by 41.2% in the 3rd quarter. Valeo Financial Advisors LLC now owns 459 shares of the specialty chemicals company’s stock valued at $181,000 after buying an additional 134 shares during the period. 76.22% of the stock is owned by hedge funds and other institutional investors.

About Sherwin-Williams

The Sherwin-Williams Company develops, manufactures, distributes, and sells paints, coatings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America, the Caribbean, Europe, Asia, and Australia. The company operates in three segments: The Americas Group, Consumer Brands Group, and Performance Coatings Group.

See Also: Balanced Fund

Analyst Recommendations for Sherwin-Williams (NYSE:SHW)

Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply